Vicor (VICR): Revisiting Valuation After Roth Capital’s New Buy Rating and Strong Earnings Momentum

Vicor (VICR) just caught investors attention after Roth Capital initiated coverage with a fresh buy rating, helping push the stock higher on the back of already strong recent earnings momentum.

See our latest analysis for Vicor.

That fresh buy call comes after a powerful run, with a 1 month share price return of about 23 percent and a roughly 97 percent 3 month share price return. The 1 year total shareholder return above 110 percent indicates that momentum has been building rather than fading.

If Vicor’s surge has you rethinking what is possible in this space, it is a good moment to scout high growth tech and AI stocks that could be primed for the next leg higher.

Yet with Vicor now trading above the average analyst target and sitting on triple digit 12 month gains, the real question is whether the rally still leaves room for upside or if markets already price in future growth.

Most Popular Narrative Narrative: 20.5% Overvalued

With Vicor last closing at 104.40 dollars against a most-followed fair value of 86.67 dollars, the narrative frames today’s price as running ahead of fundamentals.

The fair value estimate remains unchanged at 86.67 dollars per share, indicating stable long term intrinsic value expectations.

Read the complete narrative.

Curious why a steady fair value still points to a premium price tag today? The narrative leans on firm growth, rich margins and a punchy future earnings multiple. Want to see exactly which long range assumptions lock in that valuation path?

Result: Fair Value of $86.67 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, lingering demand volatility and heavy reliance on unpredictable licensing income could quickly undermine the optimistic valuation path that underpins today’s premium price.

Find out about the key risks to this Vicor narrative.

Build Your Own Vicor Narrative

If you see the story differently, or want to dig into the numbers yourself, you can build a personalized view in minutes using Do it your way.

A great starting point for your Vicor research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.

Looking for more investment ideas?

Do not stop at one exciting story. Use the Simply Wall St Screener to uncover other opportunities that could reshape your portfolio before everyone else notices.

• Capture potential turnaround stories early by targeting these 3624 penny stocks with strong financials that pair low share prices with improving financial strength.
• Position yourself at the forefront of intelligent automation by tracking these 25 AI penny stocks that combine rapid growth with scalable technology advantages.
• Identify value oriented opportunities by scanning these 914 undervalued stocks based on cash flows where current prices still trail long term cash flow potential.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com